Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 9,111 | 6,957 | 28,935 | -1,917 | 11,992 |
| Gross Profit | 9,111 | 6,957 | 28,935 | -1,917 | 11,992 |
| Operating Expenses | 153,881 | 146,000 | 142,938 | 137,975 | 143,099 |
| Operating Income | -144,770 | -139,043 | -114,003 | -139,892 | -131,107 |
| Other Income | 9,058 | -7,932 | 6,567 | 7,731 | 8,883 |
| Pre-tax Income | -135,712 | -146,975 | -107,436 | -132,161 | -122,224 |
| Net Income Continuous | -135,712 | -146,975 | -107,436 | -132,161 | -122,224 |
| Net Income | $-135,712 | $-146,975 | $-107,436 | $-132,161 | $-122,224 |
| EPS Basic Total Ops | -1.34 | -1.52 | -1.12 | -1.47 | -1.38 |
| EPS Basic Continuous Ops | -1.34 | -1.52 | -1.13 | -1.46 | -1.38 |
| EPS Diluted Total Ops | -1.34 | -1.52 | -1.12 | -1.47 | -1.38 |
| EPS Diluted Continuous Ops | -1.34 | -1.52 | -1.13 | -1.46 | -1.38 |
| EPS Diluted Before Non-Recurring Items | -1.34 | -1.31 | -1.06 | -1.46 | -1.38 |
| EBITDA(a) | $-142,162 | $-136,444 | $-111,491 | $-137,426 | $-128,817 |